AzTrials
AzTrials

TelemedicineNCT05617560

Hospital@Home: Telemedical Care After Inpatient Hospital Stay

A study testing Telemedical care in people with Telemedicine, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pilot study is to investigate a patient transfer path from the hospital to Hospital@Home to their general practitioners (GPs) using telemedical procedures. Telemedical support will be executed by Medgate who will refer the patients to their GPs after the telemedical consultations are completed. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Telemedicine
What is being tested?
Telemedical care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
234 participants
Where
1 siteSwitzerland
Study dates
26 Oct 2022to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Written informed consent as documented by signature from the patient
  • Planned hospital discharge
  • Intended follow-up care, that is manageable with telemedicine

Who cannot join

  • Significant mental or cognitive impairment
  • Unable or not willing to sign informed consent
  • Unable to understand German
  • No possibility of telecommunication or use of such (app or phone)

Trial locations and contacts

1 site in 1 country.

Switzerland1 site

  • University Hospital Basel, Division of Internal Medicine

    Basel, 4031

Other trials in Switzerland

About this study

This pilot study is to investigate a patient transfer path from the hospital to Hospital@Home to their general practitioners (GPs) using telemedical procedures. Telemedical support will be executed by Medgate who will refer the patients to their GPs after the telemedical consultations are completed. Inclusion criteria is the need for short time follow up procedures that can be handled by telemedicine. Throughout the study, patient and stakeholder satisfaction will be measured and data-based methods will be developed to assess patient transfer success. Overall, new information flow and communication between the stakeholders (hospital, telemedicine and general practitioners) are defined and tested. The Hospital@Home pilot study is intended to become a flagship project for new healthcare models.

Read the detailed description

This pilot study is to investigate a patient transfer path from the hospital to Hospital@Home to their general practitioners (GPs) using telemedical procedures.

The following study procedures are depicted:

Visit 1 (screening): Patients provide the name of their GP, the means of transport that they usually take to him, demographic data, past medical history and current medications.

The study team contacts the GP afterwards by phone to get his/her consent. The study team informs Medgate about the participant and the procedure. Next to that it will link Medgate technically to the case of the patient that Medgate can see the patient's documentation in the University Hospital Basel (USB) -ePortal.

Visit 2 (transfer): Before leaving the hospital, the participant will be instructed by a member of the study team on how and when to fill out the questionnaires. At this time, the participant and the USB physician will answer the first one. After Medgate has received the information from USB that the patient has been included in the study and has left the hospital, the patient will be contacted by Medgate and the appointment for the first teleconsultation will be made according to information from USB. The patient will be called by Medgate physician at the agreed time and the teleconsultation will be performed. Depending on the patient's condition and health status, further appointments are scheduled. The patient has the possibility to contact Medgate at any time (24/7) in case of an urgent medical matter. The patient receives the physician's recommendations in written form after each teleconsultation as their treatment plan via app or e-mail.

Visit 3...x (telecare): In advance of the first consultation via Medgate, the Medgate physician will log in into the USB-ePortal to get all important medical information about the patient. After that consultation the patient and the Medgate physician will answer a questionnaire. Depending on the clinical condition, health status and from this resulted procedure, the participant will be contacted several times. After the last consultation the Medgate physician will answer a questionnaire and will refer the patient back to the GP. The documentation will be sent to the GP and the USB. The GP will get a questionnaire as well.

Visit 4 (follow-up): On day x after the last consultation via Medgate the GP and the participant will answer the last questionnaire.

Conditions
Telemedicine
Being tested
Telemedical care
Keywords
Medgate, Patient transfer path, Telemedical care, Telephone consultation, Videocall consultation, ergebnisorientiertes Patientenassessment - AcuteCare (ePA-AC), Patient-Reported Experience Measures Survey (PREMS), Patient Reported Outcome Measures Survey (PROMS)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Telemedical careOther

    Telemedical care will be provided to all participants after stationary hospital stay. This care will be in form of telephone consultations and / or videocall consultations with a medical physician. Depending on the individual medical history and the planned aftercare and procedure of the participants it will comprise of one or more such telephone consultations.

Study groups in NCT05617560
Study groupRoleWhat they receive
Telemedical careExperimentalNot described
Receives: Other: Telemedical care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in PROMS (patient-reported outcome measures survey)

    PROMS (patient-reported outcome measures survey): measure to asses a patient's quality of life affected by state of health. 6 standardized questions for self-assessment of the patient's state of health by the patient. The content of the questions relates to mobility, self-care, general activities, pain, anxiety and health in general. Questions are answered using Likert scales and qualitative free text answers. Scoring: 5 multiple choice questions (example pain: no pain, mild -, moderate -, severe -, extreme pain); (example general health: Scale from 0 - 100 (0 = worst health, 100 = best health imaginable)).

    Measured: From Visit 2 (Transfer) up to Visit 4 (Follow up), approx. 2 weeks

  2. PREMS (patient reported experience measure survey) conducted by patients

    PREMS (patient reported experience measure survey): satisfaction related questionnaire. Questions are answered using Likert scales (Format: 1: You completely disagree with this statement. 2: - not to. 3: - rather not to. 4: - neither accept nor reject them. 5: - a little too. 6: - majority to 7: You very much agree with this statement)

    Measured: From Visit 2 (Transfer) up to Visit 4 (Follow up), approx. 2 weeks

  3. PREMS (patient reported experience measure survey) conducted by physicians

    PREMS (patient reported experience measure survey): satisfaction related questionnaire. Questions are answered using Likert scales (Format: 1: You completely disagree with this statement. 2: - not to. 3: - rather not to. 4: - neither accept nor reject them. 5: - a little too. 6: - majority to 7: You very much agree with this statement)

    Measured: From Visit 2 (Transfer) up to Visit 4 (Follow up), approx. 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2022
  2. Study start26 Oct 2022
  3. Primary completion31 Dec 2024
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Model description
investigator-initiated, prospective, single-center clinical intervention study
Masking
None (open label)
Enrolment
234 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05617560
Sponsor's protocol ID
2022-01440; am22Eckstein2
Status last verified
Apr 2025
First submitted
7 Nov 2022
Last updated
11 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Gram JS, Meier R, Holz B, Abdelhamid K, Lang T, Imfeld L, Rotte H, Warthmann I, Zweipfenning S, Casper K, Haner R, Schodler AL, Thai W, Abel C, Aeschlimann N, Ingrisani M, Ledergerber I, Sommer-Meyer C, Mayer V, Handke M, Kaufmann J, van der Lely S, Rimner T, Gujer C, Ganarin R, Angerer A, Hirsch S, Suter S, Schmitz-Grosz K, Eckstein J. Evaluating a Telemedical Follow-Up Program for Continuity of Care After Hospital Discharge: Prospective Clinical Intervention Study. JMIR Form Res. 2026 Mar 27;10:e85467. doi: 10.2196/85467.

    PubMed 41894547

Questions about this trial

What is this clinical trial studying?

A study testing Telemedical care in people with Telemedicine, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in PROMS (patient-reported outcome measures survey) (time frame: From Visit 2 (Transfer) up to Visit 4 (Follow up), approx. 2 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05617560, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2025.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in